These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 16973008)

  • 21. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
    Moliterno DJ; Topol EJ
    Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a 'ménage à trois'?
    McFadden EP
    Eur Heart J; 2001 Jul; 22(13):1067-9. PubMed ID: 11428845
    [No Abstract]   [Full Text] [Related]  

  • 24. Facilitated percutaneous coronary intervention: validating the open artery hypothesis.
    Runyon JP
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():22B-26B. PubMed ID: 10731296
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognosis and treatment of non-Q-wave myocardial infarction].
    Fujii M; Saito M
    Kokyu To Junkan; 1992 Jul; 40(7):661-6. PubMed ID: 1518972
    [No Abstract]   [Full Text] [Related]  

  • 26. [Angina pectoris--preliminary stage to a myocardial infarct].
    Mertens HM
    Dtsch Krankenpflegez; 1991 Feb; 44(2):82-5. PubMed ID: 1672272
    [No Abstract]   [Full Text] [Related]  

  • 27. New trials and therapies for acute myocardial infarction.
    Gumina RJ
    Med Clin North Am; 2007 Jul; 91(4):729-49; xii. PubMed ID: 17640545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic adjunctive therapy for acute myocardial infarction.
    Landreneau JW
    J La State Med Soc; 1992 May; 144(5):223-6. PubMed ID: 1351917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytic treatment of acute myocardial infarct. 3].
    Gabriel HM; Soares-Costa JT; Soares-Costa TJ
    Acta Med Port; 1998 May; 11(5):431-8. PubMed ID: 9951053
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular news. C-PORT PCI.
    SoRelle R
    Circulation; 2000 Dec; 102(25):E9050-1. PubMed ID: 11138602
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status and future prospects for acute myocardial infarction therapy.
    Topol EJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III6-13. PubMed ID: 14605014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of unstable angina soon after myocardial infarction.
    Seth A; Perry RA; Shiu MF
    Br J Hosp Med; 1988 May; 39(5):400-2, 404-6, 408. PubMed ID: 2898267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating time to reperfusion in acute myocardial infarction: prehospital and emergency department strategies, systems of care, and pharmacologic interventions.
    Ornato JP
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S49-60. PubMed ID: 17224891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of acute myocardial infarction and unstable coronary syndrome].
    Gjesdal K; Aursnes I
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2774-7. PubMed ID: 1977206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical prophylaxis for the post myocardial infarct patient.
    Cohen LS
    Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
    Cannon CP
    Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplement on acute coronary syndromes: introduction.
    Califf RM
    Circulation; 2003 Oct; 108(16 Suppl 1):III1-5. PubMed ID: 14605013
    [No Abstract]   [Full Text] [Related]  

  • 40. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.